Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, November 24, 2020
[ Tue, Nov 24th 2020
] - WOPRAI
[ Tue, Nov 24th 2020
] - WOPRAI
[ Tue, Nov 24th 2020
] - WOPRAI
[ Tue, Nov 24th 2020
] - WOPRAI
[ Tue, Nov 24th 2020
] - WOPRAI
[ Tue, Nov 24th 2020
] - WOPRAI
[ Tue, Nov 24th 2020
] - WOPRAI
[ Tue, Nov 24th 2020
] - WOPRAI
Mon, November 23, 2020
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
[ Mon, Nov 23rd 2020
] - WOPRAI
Raghuram Selvaraju Maintained (SPRO) at Strong Buy with Increased Target to $33 on, Nov 23rd, 2020
Raghuram Selvaraju of HC Wainwright & Co., Maintained "Spero Therapeutics, Inc." (SPRO) at Strong Buy with Increased Target from $28 to $33 on, Nov 23rd, 2020.
Raghuram has made no other calls on SPRO in the last 4 months.
There is 1 other peer that has a rating on SPRO. Out of the 1 peers that are also analyzing SPRO, 0 agree with Raghuram's Rating of Hold.
This is the rating of the analyst that currently disagrees with Raghuram
- Josh Schimmer of "Evercore ISI Group" Initiated at Buy and Held Target at $70 on, Tuesday, September 29th, 2020
